Epizyme, Inc.
EPZMDelisted Aug 12, 2022- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001571498
Epizyme, Inc. was delisted on Aug 12, 2022; its insiders filed their last Form 4 on Aug 16, 2022; 94 institutions reported holding it in 13F filings for Q2 2022, worth $187.0M in total; no superinvestor held it.
13F holders, Q4 2022
Institutional positions in Epizyme, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
EPZM is no longer listed, and 13F filings after Q2 2022 list far fewer holders. See Q2 2022
- Institutional holders
- 0
- −1 vs. Q3 2022
- Shares held
- 0
- 0 vs. Q3 2022
- Total value
- $0
- −$4.00K (−100.0%) vs. Q3 2022
- New holders
- 0
- 0 more added
- Sold out
- 1
- 0 more reduced
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting EPZM on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 1 | $4.00K |
| Q2 2022 | 94 | $187.0M |
| Q1 2022 | 120 | $177.5M |
| Q4 2021 | 132 | $212.1M |
| Q3 2021 | 116 | $479.9M |
| Q2 2021 | 127 | $790.2M |
| Q1 2021 | 140 | $838.5M |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Epizyme, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Tudor Investment Corp Et Al | 0 | $0 | 0.00% | – | Sold out |